WEX Pharmaceuticals Inc. is a biopharmaceutical company based in Vancouver, Canada and is developing a late-stage non-opioid analgesic, Halneuron®.
Halneuron is a highly selective sodium channel blocker and represents a breakthrough in painkiller technology:
- Non-addictive, no withdrawal symptoms and no euphoria
- No build of up of tolerance over time
- A long duration of pain relief with minimal side effects
- Safe for human use and tested in over 500 patients to date
Halneuron is entering into Phase III clinical trials for chemotherapy induced neuropathic pain and concurrently being tested in other pain indications.